Advertisement

Tadalafil For Pulmonary Hypertension: 40 Mg Once-Daily Guide

Comprehensive guide to tadalafil (Adcirca, Talmanco) for managing pulmonary hypertension symptoms and improving exercise capacity.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Tadalafil is a medication specifically approved for treating pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lung arteries strains the heart. Branded as

Adcirca

or

Talmanco

, it relaxes blood vessels in the lungs, easing heart workload and enhancing exercise tolerance.

About tadalafil tablets for pulmonary hypertension

**Tadalafil** targets

pulmonary arterial hypertension (PAH)

, classified as WHO Group 1 pulmonary hypertension. This progressive disease thickens lung arteries, raising pressure and complicating blood flow from the heart to lungs. Without treatment, it leads to right heart failure.

Tadalafil, a

phosphodiesterase type-5 (PDE5) inhibitor

, boosts cyclic guanosine monophosphate (cGMP) levels. This substance relaxes pulmonary arteries, lowers pressure, and improves oxygen delivery, enhancing exercise capacity and quality of life.

Approved by the FDA in 2009 as

Adcirca

for PAH (distinct from

Cialis

for erectile dysfunction), it offers once-daily dosing convenience over thrice-daily sildenafil.

Key facts about tadalafil tablets for pulmonary hypertension

  • About tadalafil tablets: Tablets (Adcirca, Talmanco) for PAH.
  • Used for: Pulmonary arterial hypertension.
  • Dose: Typically 40 mg once daily.
  • Side-effects: Headache, flushing, muscle pain, indigestion.

Before taking tadalafil tablets for pulmonary hypertension

Who can and cannot take tadalafil tablets

Most adults with PAH can use tadalafil. Not suitable if allergic to tadalafil or nitrates user (e.g., GTN for angina), as combination risks severe blood pressure drop.

Use caution with:

  • Recent heart attack/stroke (past 6 months).
  • Hypotension (<90/50 mmHg).
  • Severe liver/kidney disease.
  • Priapism history.
  • Retinal issues (e.g., NAION).
  • Deformed penis (e.g., Peyronie’s).

Safe for pediatrics per 2019 World Symposium, though trials small.

Other medicines, food/drink, alcohol to avoid

Do not take with:

  • Nitrates (e.g., GTN).
  • Riociguat (Adempas®).
  • Other PAH drugs without advice.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir).

Food/drink: No grapefruit juice (raises tadalafil levels). Alcohol may worsen hypotension.

Pregnancy and breastfeeding

Avoid in pregnancy (limited data; PAH risky). Breastfeeding: minimal excretion, discuss benefits/risks.

Taking other medicines

Inform doctor of all medications, including bosentan (reduces effect slightly).

Common questions about tadalafil tablets for pulmonary hypertension

How and when to take tadalafil tablets

Take

40 mg once daily

, anytime, with/without food. Swallow whole. If dose missed, take soon as remembered unless near next; never double.

Taking tadalafil tablets with other medicines for pulmonary hypertension

Often combined with endothelin antagonists (bosentan) or prostanoids. PHIRST trial showed benefits on bosentan background, though blunted.

Taking an extra dose of tadalafil tablets by mistake

Unlikely harm; contact doctor if concerned.

Will my dose go up or down?

Start 20-40 mg; adjust based on response/tolerance. Liver/kidney issues may need lower dose.

Side effects of tadalafil tablets

Common, usually mild/transient. Report persistent/severe issues.

Common side effects

Side effectHow to cope
Headache (11-15%)Paracetamol; rest; hydrate. Doctor if severe.
Flushing (10-13%)Cool room; loose clothes.
Myalgia/back pain (5-9%)Paracetamol; heat. Rare rhabdomyolysis.
Dyspepsia (7-10%)Small meals; antacids.
Nasal congestion (4-9%)Saline spray.

Serious side effects

  • Sudden vision/hearing loss: emergency.
  • Chest pain: stop, seek help.
  • Prolonged erection (>4h): urgent care.
  • Hypotension symptoms.
  • NAION risk (rare).

PHIRST trial side effects

Headache (most common), myalgia, flushing, nasopharyngitis, pain in extremity.

How and when to take tadalafil tablets

Standard dose:

40 mg orally once daily

. Consistent timing aids adherence. No IV form; switch to IV sildenafil if needed.

Taking tadalafil tablets with other medicines for pulmonary hypertension

Combines well; PHIRST: 40 mg improved 6MWD 33m overall, 44m bosentan-naive.

Pregnancy and breastfeeding while taking tadalafil tablets

See above; PAH pregnancy high-risk.

Further information about tadalafil tablets

Analysing your ‘6-minute walk distance’ test result

Key PAH metric: distance walked in 6 min. PHIRST: tadalafil 40 mg +33m vs placebo (p<0.01).

Staying on tadalafil tablets

Long-term; monitor BP initially. Improves hemodynamics: ↓mPAP 4-8 mmHg, ↓PVR 200+ dyne-sec-cm⁻⁵.

Stopping tadalafil tablets suddenly

Taper if discontinuing; sudden stop risks PAH worsening.

Frequently asked questions about tadalafil

Everything you need to know about being prescribed tadalafil

  1. What is tadalafil? PDE5 inhibitor relaxing lung vessels for PAH.
  2. Why prescribe tadalafil? Improves exercise (6MWD +33m), delays worsening.
  3. How does it work? ↑cGMP → vasodilation.
  4. When to take? Once daily.
  5. Brands? Adcirca, Talmanco.
  6. With Cialis? Separate; Adcirca higher dose/no ED effect.
  7. Long-term? Yes, extension studies safe.
  8. Children? Recommended.
  9. Alcohol? Limit.
  10. Missed dose? Take ASAP, skip if late.

Understanding WHO functional class

ClassDescription
INo limitation ordinary activity.
IISlight limitation; ordinary activity discomfort.
IIIMarked limitation; less than ordinary uncomfortable.
IVSymptoms at rest; unable any activity.

PHIRST: no significant WHO class change.

Tadalafil with sildenafil

Do not combine; both PDE5i. Sequential ok post-guidelines.

References

  1. Tadalafil therapy for pulmonary arterial hypertension — Jing ZC et al. Journal of the American College of Cardiology. 2009-06-09. https://pubmed.ncbi.nlm.nih.gov/19470885/
  2. Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) — American College of Cardiology. 2010-02-23. https://www.acc.org/latest-in-cardiology/clinical-trials/2010/02/23/19/16/phirst
  3. Tadalafil (Adcirca) — Pulmonary Hypertension Association. Accessed 2026. https://phassociation.org/pulmonary-hypertension/treatments/targeted-therapies/tadalafil/
  4. The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension — Galiè N et al. Vascular Health and Risk Management. 2010-04-19. https://pmc.ncbi.nlm.nih.gov/articles/PMC2868348/
  5. Tadalafil — Pulmonary Hypertension Association UK. Accessed 2026. https://www.phauk.org/about-ph-2/treatment-for-pulmonary-hypertension/oral-therapies/phosphodiesterase-5-inhibitors/tadalafil/
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete